Circulating Tumor Cells Market 2020 Research and Clinical Analysis - Menarini-Silicon Biosystems, Qiagen (Adnagen), Celsee

The Circulating Tumor Cells Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

In 2018, the global Circulating Tumor Cells market size was 730 million US$ and it is expected to reach 3230 million US$ by the end of 2025, with a CAGR of 20.4% during 2019-2025.

Buy The Report:
https://www.marketinsightsreports.com/report/purchase/03131147240?mode=su?source=openpr&Mode=RJ

Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.

The report presents the market competitive landscape and a corresponding detailed analysis of the major vendor/key players in the market. Top Companies in the Global Circulating Tumor Cells Market: Menarini-Silicon Biosystems, Qiagen (Adnagen), Advanced Cell Diagnostics, ApoCell, Epic Sciences, Greiner Bio-one GmbH, Cynvenio, SurExamBio-Tech, Fluxion Biosciences, Ikonisys, Hangzhou Watson Biotech, Biocept, CytoTrack, Guangzhou Wondfo Biotech, Celsee, Clearbridge Biomedics, ANGLE plc and others.

Latest news and developments:

March 28, 2019 - QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced the launch of new solutions designed to advance cancer research as part of its highlights at the American Association for Cancer Research (AACR) 2019 Annual Meeting from March 29 to April 3, 2019, in Atlanta, Georgia. More than 30 studies being presented at AACR 2019 cite molecular testing tools from QIAGEN's Sample to Insight portfolio.

New solution bundles for all QIAseq and QIAact DNA panels for next-generation sequencing (NGS), integrating its market-leading CLC Genomics Workbench and QIAGEN Clinical Insight-Interpret software with these assays for seamless secondary analysis and tertiary interpretation of complex genomic data.

QIAGEN is introducing its exoRNeasy Midi and Maxi Kits for isolation of exosomes and other extracellular vesicles from urine and other samples, as well as the miRNeasy 96 Advanced QIAcube HT Kit for automated purification of total RNA, including miRNA, from serum and plasma samples. These are two novel liquid biopsy workflows for cancer research designed to enable non-invasive extraction and purification of ribonucleic acid (RNA).

April 09, 2020: Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that it has acquired Celsee, Inc., a company that offers instruments and consumables for the isolation, detection, and analysis of single cells. Terms of the acquisition were not disclosed. Bio-Rad will discuss the acquisition in more detail during its first-quarter 2020 financial results conference call.

Global Circulating Tumor Cells Market Split by Product Type and Applications:

This report segments the market on the basis of Types are:

CTC Enrichment
CTC Detection
CTC Analysis

On the basis of Application, the market is segmented into:

Breast Cancer
Prostate Cancer
Colorectal Cancer
Lung Cancer
Other

Click the link to get a Sample Copy of the Report:

https://www.marketinsightsreports.com/reports/03131147240/global-circulating-tumor-cells-market-size-status-and-forecast-2019-2025/inquiry?source=openpr&Mode=RJ

Regional Analysis For Circulating Tumor Cells Market:

For comprehensive understanding of market dynamics, the global Circulating Tumor Cells market is analyzed across key geographies namely:

North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.

Circulating Tumor Cells Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger and acquisitions along with trending innovation and business policies are reviewed in the report. The report contains basic, secondary and advanced information pertaining to the Market global status and trend, market size, share, growth, trends analysis, segment and forecasts from 2020-2026.

Following are major Table of Content of Circulating Tumor Cells Market:

- Global Market Overview, Drivers, Restraints and Opportunities, Segmentation overview

- Global Market competition by top Players

- Analysis by Regions

- Consumption by Regions

- Consumption, By Types, Revenue and Market share by Types

- Consumption, By Applications, Market share (%) and Growth Rate by Applications

- Complete profiling and analysis of Players

- Industrial Chain, Sourcing Strategy and Downstream Buyers

- Marketing Strategy Analysis, Distributors/Traders

- Global Market Effect Factors Analysis

- Global Market Forecast

- Global Market Research Findings and Conclusion, Appendix, methodology and data source

Finally, all aspects of the Global Market are quantitatively as well qualitatively assessed to study the Global as well as regional market comparatively. This market study presents critical information and factual data about the market providing an overall statistical study of this market on the basis of market drivers, limitations and its future prospects. The report supplies the international economic competition with the assistance of Porter's Five Forces Analysis and SWOT Analysis.

For More Information On This Report, Please Visit: https://www.marketinsightsreports.com/reports/03131147240/global-circulating-tumor-cells-market-size-status-and-forecast-2019-2025?source=openpr&Mode=RJ

We Offer Customization On Report Based On Specific Client Requirement:

- Free country Level analysis for any 5 countries of your choice.

- Free Competitive analysis of any 5 key market players.

- Free 40 analyst hours to cover any other data point.

Browse Related Reports:

Circulating Tumor Cells (CTCs) Prognostic Technologies Market:

https://www.marketinsightsreports.com/reports/07151359605/global-circulating-tumor-cells-ctcs-prognostic-technologies-market-size-status-and-forecast-2019-2025?source=openpr&Mode=RJ

Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market:

https://www.marketinsightsreports.com/reports/02021076775/global-circulating-tumor-cells-ctcs-and-cancer-stem-cells-cscs-market-size-status-and-forecast-2019-2025?source=openpr&Mode=RJ

How we have factored the effect of Covid-19 in our report:

All the reports that we list have been tracking the impact of COVID-19. Both upstream and downstream of the entire supply chain has been accounted for while doing this. Also, where possible, we will provide an additional COVID-19 update supplement/report to the report in Q3, please check for with the sales team.

ABOUT US:
MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

CONTACT US:
Irfan Tamboli (Head of Sales) - Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com

This release was published on openPR.